MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study
Restricted accessOtherFirst published online February, 2010
MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study
3,4-methylenedioxymethamphetamine (MDMA) users have impaired verbal memory, and voxel-based morphometry has shown decreased grey matter in Brodmann area (BA) 18, 21 and 45. Because these regions play a role in verbal memory, we hypothesized that MDMA users would show altered brain activation in these areas during performance of a functional magnetic resonance imaging (fMRI) task that probed semantic verbal memory. Polysubstance users enriched for MDMA exposure participated in a semantic memory encoding and recognition fMRI task that activated left BA 9, 18, 21/22 and 45. Primary outcomes were percent blood oxygen level-dependent signal change in left BA 9, 18, 21/22 and 45, accuracy and response time. During semantic recognition, lifetime MDMA use was associated with decreased activation in left BA 9, 18 and 21/22 but not 45. This was partly influenced by contributions from cannabis and cocaine use. MDMA exposure was not associated with accuracy or response time during the semantic recognition task. During semantic recognition, MDMA exposure was associated with reduced regional brain activation in regions mediating verbal memory. These findings partially overlap with previous structural evidence for reduced grey matter in MDMA users and may, in part, explain the consistent verbal memory impairments observed in other studies of MDMA users.
Allen, PP, Cleare, AJ, Lee, F., Fusar-Poli, P., Tunstall, N., Fu, CH, et al. (2006) Effect of acute tryptophan depletion on pre-frontal engagement. Psychopharmacology ( Berl) 187: 486-497.
2.
Amunts, K., Weiss, PH, Mohlberg, H., Pieperhoff, P., Eickhoff, S., Gurd, JM, et al. (2004) Analysis of neural mechanisms underlying verbal fluency in cytoarchitectonically defined stereotaxic space-the roles of Brodmann areas 44 and 45. Neuroimage22: 42-56.
3.
Ardila, A., Rosselli, M., Strumwasser, S. ( 1991) Neuropsychological deficits in chronic cocaine abusers . Int J Neurosci57: 73-79.
4.
Babiloni, C., Ferretti, A., Del, GC, Carducci, F., Vecchio, F., Romani, GL, et al. (2005) Human cortical responses during one-bit delayed-response tasks: an fMRI study. Brain Res Bull65: 383-390.
5.
Back-Madruga, C., Boone, KB, Chang, L., Grob, CS, Lee, A., Nations, H., et al. (2003) Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users. Clin Neuropsychol17: 446-459.
6.
Baxter, MG, Gaffan, D., Kyriazis, DA, Mitchell, AS ( 2008) Dorsolateral prefrontal lesions do not impair tests of scene learning and decision-making that require frontal-temporal interaction . Eur J Neurosci28: 491-499.
7.
Block, RI, O’Leary, DS, Hichwa, RD, Augustinack, JC, Boles Ponto, LL, Ghoneim, MM, et al. (2002) Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacol Biochem Behav72: 237-250.
8.
Bolla, KI, Brown, K., Eldreth, D., Tate, K., Cadet, JL ( 2002) Dose-related neurocognitive effects of marijuana use. Neurology59: 1337-1343.
9.
Bolla, KI, McCann, UD, Ricaurte, GA ( 1998) Memory impairment in abstinent MDMA ("Ecstasy") users . Neurology51: 1532-1537.
10.
Bondi, MW, Houston, WS, Eyler, LT, Brown, GG ( 2005) fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology64: 501-508.
11.
Booth, JR, Burman, DD, Meyer, JR, Gitelman, DR, Parrish, TB, Mesulam, MM ( 2002) Modality independence of word comprehension. Hum Brain Mapp16: 251-261.
12.
Buchert, R., Obrocki, J., Thomasius, R., Vaterlein, O., Petersen, K., Jenicke, L., et al. (2001) Long-term effects of ‘ecstasy’ abuse on the human brain studied by FDG PET. Nucl Med Commun22: 889-897.
13.
Butchert, R., Thomasius, R., Wilke, F., Peterson, K., Nebeling, B., Obrocki, J., et al. (2004) A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters. Am J Psychiatry161: 1181-1189.
14.
Butler, SG, Meegan, MJ ( 2008) Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter. Curr Med Chem15: 1737-1761.
15.
Chang, L., Yakupov, R., Cloak, C., Ernst, T. ( 2006) Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain129: 1096-1112.
16.
Chou, TL, Booth, JR, Bitan, T., Burman, DD, Bigio, JD, Cone, NE, et al. (2006) Developmental and skill effects on the neural correlates of semantic processing to visually presented words. Hum Brain Mapp27: 915-924.
17.
Cowan, RL ( 2007) Neuroimaging research in human MDMA users: a review. Psychopharmacology (Berl) 189: 539-556.
18.
Cowan, RL, Bolo, NR, Dietrich, M., Haga, E., Lukas, SE, Renshaw, PF ( 2007) Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug users. Psychiatry Res155: 179-188.
19.
Cowan, RL, Lyoo, IK, Sung, SM, Ahn, KH, Kim, MJ, Hwang, J., et al. (2003) Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study. Drug Alcohol Depend72: 225-235.
20.
Cowan, RL, Roberts, DM, Joers, JM ( 2008) Neuroimaging in human MDMA (Ecstasy) users. Ann N Y Acad Sci1139: 291-298.
21.
Curran, HV, Verheyden, SL ( 2003) Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function . Psychopharmacology (Berl) 169: 91-103.
22.
Daumann J.r, J, Fischermann, T., Heekeren, K., Thron, A., Gouzoulis-Mayfrank, E. ( 2004) Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study. Biol Psychiatry56: 349-355.
23.
Daumann, J., Fimm, B., Willmes, K., Thron, A., Gouzoulis-Mayfrank, E. ( 2003) Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study. Brain Res Cogn Brain Res16: 479-487.
24.
Daumann, J., Fischermann, T., Heekeren, K., Henke, K., Thron, A., Gouzoulis-Mayfrank, E. ( 2005) Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users. Psychopharmacology (Berl) 180: 607-611.
25.
de Almeida, SP, Silva, MT ( 2003) Ecstasy (MDMA): effects and patterns of use reported by users in Sao Paulo. Rev Bras Psiquiatr25: 11-17.
26.
de Win, MM, Jager, G., Vervaeke, HK, Schilt, T., Reneman, L., Booij, J., et al. (2005) The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. Int J Methods Psychiatr Res14: 167-185.
27.
de Win, MM, Reneman, L., Reitsma, JB, den Heeten, GJ, Booij, J.van den, BW ( 2004) Mood disorders and serotonin transporter density in ecstasy users-the influence of long-term abstention, dose, and gender. Psychopharmacology (Berl) 173: 376-382.
28.
Easton, N., Marsden, CA ( 2006) Ecstasy: are animal data consistent between species and can they translate to humans? J Psychopharmacol20: 194-210.
29.
Fantegrossi, WE, Woolverton, WL, Kilbourn, M., Sherman, P., Yuan, J., Hatzidimitriou, G., et al. (2004) Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Neuropsychopharmacology29: 1270-1281.
30.
Fitzgerald, PB, Oxley, TJ, Laird, AR, Kulkarni, J., Egan, GF, Daskalakis, ZJ ( 2006) An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depression. Psychiatry Res148: 33-45.
31.
Fox, HC, Parrott, AC, Turner, JJ ( 2001) Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. J Psychopharmacol15: 273-281.
32.
Friedman, L., Kenny, JT, Wise, AL, Wu, D., Stuve, TA, Miller, DA, et al. (1998) Brain activation during silent word generation evaluated with functional MRI. Brain Lang64: 231-256.
33.
Funahashi, S. ( 2006) Prefrontal cortex and working memory processes. Neuroscience139: 251-261.
34.
Genovese, CR, Lazar, NA, Nichols, T. ( 2002) Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage15: 870-878.
35.
Gibb, JW, Johnson, M., Stone, D., Hanson, GR ( 1990) MDMA: historical perspectives. Ann N Y Acad Sci600: 601-611.
36.
Gouzoulis-Mayfrank, E., Daumann, J. ( 2006) The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. J Psychopharmacol20: 188-193.
37.
Gouzoulis-Mayfrank, E., Fischermann, T., Rezk, M., Thimm, B., Hensen, G., Daumann, J. ( 2005) Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use. Drug Alcohol Depend78: 317-323.
38.
Green, AR, Mechan, AO, Elliott, JM, O’Shea, E., Colado, MI ( 2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev55: 463-508.
39.
Herholz, K., Ehlen, P., Kessler, J., Strotmann, T., Kalbe, E., Markowitsch, HJ ( 2001) Learning face-name associations and the effect of age and performance: a PET activation study. Neuropsychologia39: 643-650.
40.
Herning, RI, Better, WE, Tate, K., Cadet, JL ( 2005) Cerebrovascular perfusion in marijuana users during a month of monitored abstinence. Neurology64: 488-493.
41.
Jacobsen, LK, Mencl, WE, Pugh, KR, Skudlarski, P., Krystal, JH ( 2004) Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects. Psychopharmacology (Berl) 173: 383-390.
42.
Jager, G., de Win, MM, van der Tweel, I., Schilt, T., Kahn, RSvan den, BW, et al. (2008) Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study. Neuropsychopharmacology33: 247-258.
43.
Jager, G., de Win, MM, Vervaeke, HK, Schilt, T., Kahn, RSvan den, BW, et al. (2007) Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study. Psychopharmacology (Berl) 193: 403-414.
44.
Johnston, LD, O’Malley, PM, Bachman, JG, Schulenberg, JG ( 2008) Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2007 (NIH Publication No. 08-6418). Bethesda, MD: National Institute on Drug Abuse.
45.
Kalechstein, AD, De La, GR, Mahoney III, JJ, Fantegrossi, WE, Newton, TF ( 2007) MDMA use and neurocognition: a meta-analytic review. Psychopharmacology (Berl) 189: 531-537.
46.
Kish, SJ ( 2002) How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? Pharmacol Biochem Behav71: 845-855.
47.
Lancaster, JL, Woldorff, MG, Parsons, LM, Liotti, M., Freitas, CS, Rainey, L., et al. (2000) Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp10: 120-131.
48.
Laws, KR, Kokkalis, J. ( 2007) Ecstasy (MDMA) and memory function: a meta-analytic update . Hum Psychopharmacol22: 381-388.
49.
Lee, AC, Robbins, TW, Graham, KS, Owen, AM ( 2002) "Pray or Prey?" dissociation of semantic memory retrieval from episodic memory processes using positron emission tomography and a novel homophone task. Neuroimage16: 724-735.
50.
Linden, DE ( 2007) The working memory networks of the human brain. Neuroscientist13: 257-267.
51.
Logothetis, NK, Pfeuffer, J. ( 2004) On the nature of the BOLD fMRI contrast mechanism. Magn Reson Imaging22: 1517-1531.
McCann, UD, Szabo, Z., Scheffel, U., Dannals, RF, Ricaurte, GA ( 1998) Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet352: 1433-1437.
54.
McCann, UD, Szabo, Z., Seckin, E., Rosenblatt, P., Mathews, WB, Ravert, HT, et al. (2005) Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB. Neuropsychopharmacology30: 1741-1750.
55.
McCann, UD, Szabo, Z., Vranesic, M., Palermo, M., Mathews, WB, Ravert, HT, et al. (2008) Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance. Psychopharmacology (Berl) 200: 439-450.
56.
Mittenberg, W., Motta, S. ( 1993) Effects of chronic cocaine abuse on memory and learning . Arch Clin Neuropsychol8: 477-483.
57.
Moeller, FG, Steinberg, JL, Dougherty, DM, Narayana, PA, Kramer, LA, Renshaw, PF ( 2004) Functional MRI study of working memory in MDMA users. Psychopharmacology (Berl) 177: 185-194.
58.
Morgan, MJ ( 2000) Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology (Berl) 152: 230-248.
59.
Obrocki, J., Buchert, R., Vaterlein, O., Thomasius, R., Beyer, W., Schiemann, T. ( 1999) Ecstasy-long-term effects on the human central nervous system revealed by positron emission tomography. Br J Psychiatry175: 186-188.
60.
Obrocki, J., Schmoldt, A., Buchert, R., Andresen, B., Petersen, K., Thomasius, R. ( 2002) Specific neurotoxicity of chronic use of ecstasy. Toxicol Lett127: 285-297.
61.
Pace-Schott, EF, Morgan, PT, Malison, RT, Hart, CL, Edgar, C., Walker, M., et al. (2008) Cocaine users differ from normals on cognitive tasks which show poorer performance during drug abstinence. Am J Drug Alcohol Abuse34: 109-121.
62.
Parrott, AC ( 2006) MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. J Psychopharmacol20: 147-163.
63.
Paulus, MP, Hozack, N., Frank, L., Brown, GG, Schuckit, MA ( 2003) Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biol Psychiatry53: 65-74.
64.
Paulus, MP, Hozack, NE, Zauscher, BE, Frank, L., Brown, GG, Braff, DL, et al. (2002) Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology26: 53-63.
65.
Paulus, MP, Tapert, SF, Schuckit, MA ( 2005) Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch Gen Psychiatry62: 761-768.
66.
Petersen, SE, Fox, PT, Posner, MI, Mintun, M., Raichle, ME ( 1988) Positron emission tomographic studies of the cortical anatomy of single-word processing. Nature331: 585-589.
67.
Poldrack, RA ( 2008) The role of fMRI in Cognitive Neuroscience: where do we stand? Curr Opin Neurobiol18: 223-227.
68.
Pope Jr, HG, Gruber, AJ, Hudson, JI, Huestis, MA, Yurgelun-Todd, D. ( 2001) Neuropsychological performance in long-term cannabis users . Arch Gen Psychiatry58: 909-915.
69.
Rauch, A., Rainer, G., Logothetis, NK ( 2008) The effect of a serotonin-induced dissociation between spiking and perisynaptic activity on BOLD functional MRI. Proc Natl Acad Sci U S A105: 6759-6764.
70.
Reneman, L., Booij, J.de, BK, Reitsma, JB, de Wolff, FA, Gunning, WB, et al. (2001a) Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet358: 1864-1869.
71.
Reneman, L., Booij, J., Schmand, B.van den, BW, Gunning, B. ( 2000a) Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology (Berl) 148: 322-324.
72.
Reneman, L., Endert, E., de Bruin, K., Lavalaye, J., Feenstra, MG, de Wolff, FA, et al. (2002) The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology26: 387-396.
73.
Reneman, L., Habraken, JB, Majoie, CB, Booij, J., den Heeten, GJ ( 2000b) MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings. AJNR Am J Neuroradiol21: 1001-1007.
74.
Reneman, L., Lavalaye, J., Schmand, B., de Wolff, FAvan den, BW, den Heeten, GJ, et al. (2001b) Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings. Arch Gen Psychiatry58: 901-906.
75.
Reneman, L., Majoie, CB, Habraken, JB, den Heeten, GJ ( 2001c) Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging. Radiology220: 611-617.
76.
Reneman, L., Majoie, CB, Schmand, B.van den, BW, den Heeten, GJ ( 2001d) Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report. Biol Psychiatry50: 550-554.
77.
Ricaurte, GA, Yuan, J., McCann, UD ( 2000) (+/-)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology42: 5-10.
78.
Robbins, TW ( 2005) Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J Comp Neurol493: 140-146.
79.
Rose, EJ, Simonotto, E., Spencer, EP, Ebmeier, KP ( 2006) The effects of escitalopram on working memory and brain activity in healthy adults during performance of the n-back task. Psychopharmacology (Berl) 185: 339-347.
80.
Schilt, T., de Win, MM, Koeter, M., Jager, G., Korf, DJvan den, BW, et al. (2007) Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Arch Gen Psychiatry64: 728-736.
81.
Schmitt, JA, Wingen, M., Ramaekers, JG, Evers, EA, Riedel, WJ ( 2006) Serotonin and human cognitive performance. Curr Pharm Des12: 2473-2486.
82.
Scholey, AB, Parrott, AC, Buchanan, T., Heffernan, TM, Ling, J., Rodgers, J. ( 2004) Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study. Addict Behav29: 743-752.
83.
Semple, DM, Ebmeier, KP, Glabus, MF, O’Carroll, RE, Johnstone, EC ( 1999) Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users. Br J Psychiatry175: 63-69.
84.
Sneider, JT, Pope Jr, HG, Silveri, MM, Simpson, NS, Gruber, SA, Yurgelun-Todd, DA ( 2008) Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers. Eur Neuropsychopharmacol18: 612-619.
85.
Solowij, N., Stephens, RS, Roffman, RA, Babor, T., Kadden, R., Miller, M., et al. (2002) Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA287: 1123-1131.
86.
Talairach, J., Tournoux, P., Rayport, M. ( 1988) Co-Planar Stereotaxic Atlas of the Human Brain: 3-D Proportional System: An Approach to Cerebral Imaging. Georg Thieme Verlag , New York, NY.
87.
Thomasius, R., Petersen, K., Buchert, R., Andresen, B., Zapletalova, P., Wartberg, L., et al. (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology (Berl) 167: 85-96.
88.
Tomasi, D., Goldstein, RZ, Telang, F., Maloney, T., Alia-Klein, N., Caparelli, EC, et al. (2007) Widespread disruption in brain activation patterns to a working memory task during cocaine abstinence. Brain Res1171: 83-92.
89.
United Nations Office on Drugs and Crimes ( 2008) 2008 World Drug Report. Vienna: United Nations Publications.
90.
van Reekum, R., Streiner, DL, Conn, DK ( 2001) Applying Bradford Hill’s criteria for causation to neuropsychiatry: challenges and opportunities. J Neuropsychiatry Clin Neurosci13: 318-325.
91.
Wager, TD, Jonides, J., Smith, EE, Nichols, TE ( 2005) Toward a taxonomy of attention shifting: individual differences in fMRI during multiple shift types. Cogn Affect Behav Neurosci5: 127-143.
92.
Wang, X., Baumann, MH, Xu, H., Morales, M., Rothman, RB ( 2005) (+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane. J Pharmacol Exp Ther314: 1002-1012.
93.
Wang, X., Baumann, MH, Xu, H., Rothman, RB ( 2004) 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Synapse53: 240-248.
94.
Wish, ED, Fitzelle, DB, O’Grady, KE, Hsu, MH, Arria, AM ( 2006) Evidence for significant polydrug use among ecstasy-using college students. J Am Coll Health55: 99-104.
95.
Yucel, M., Solowij, N., Respondek, C., Whittle, S., Fornito, A., Pantelis, C., et al. (2008) Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry65: 694-701.
96.
Zakzanis, KK, Young, DA, Radkhoshnoud, NF ( 2002) Attentional processes in abstinent methylenedioxymethamphetamine (ecstasy) users. Appl Neuropsychol9: 84-91.
